Toxicities from the therapy were predominantly associated with lymphodepletion and high-dose interleukin 2 (IL-2), including grade 3 toxicities of neutropenia, anemia, thrombocytopenia, febrile neutropenia as a consequence of lymphodepletion, capillary leak syndrome, and hyperbilirubinemia. Here, IL2 is linked to anemia (phenotype).